Trial Watch · Psychiatry & Cognitive Neurology

Clinical trials in Psychiatry & Cognitive Neurology, ranked by methodological rigor and ordered by most recent.

45 trials indexed
Multimodal AI System Matches Clinicians in Simulated Telehealth Diagnostics
PIVOTAL TRIAL · LAST 30 DAYS
Randomized Controlled Trial Nature Medicine

Multimodal AI System Matches Clinicians in Simulated Telehealth Diagnostics

A new AI system, multimodal AMIE, integrates diverse data types to achieve high diagnostic accuracy and conversational quality in simulated telehealth

May 16, 2026 Read the trial →
Tea Polyphenols Mitigate Brain Changes, Anxiety in Aged Diabetic Rats Randomized Controlled Trial
Brain Research

Tea Polyphenols Mitigate Brain Changes, Anxiety in Aged Diabetic Rats

A preclinical study in aged T2DM rats suggests tea polyphenol intervention may improve hippocampal structure, function, and behavior.

May 18, 2026
Sternal Vibration Plus Mindfulness Improves Body Awareness, White Matter in Trauma Non-Randomized Controlled Trial
Neuropsychopharmacology

Sternal Vibration Plus Mindfulness Improves Body Awareness, White Matter in Trauma

A study in trauma-exposed adults found sternal vibration combined with mindfulness meditation enhanced interoceptive awareness and increased neurite.

May 17, 2026
CTBS to Right DLPFC Reduces Heavy Drinking Relapse Risk in AUD Over 12 Months Randomized Controlled Trial
Biological Psychiatry

CTBS to Right DLPFC Reduces Heavy Drinking Relapse Risk in AUD Over 12 Months

Continuous theta-burst stimulation to the right DLPFC lowered heavy-drinking relapse risk in AUD over 12 months in a randomized trial.

May 17, 2026
ED Nudge Strategy Increases Naltrexone Prescribing for Alcohol Misuse Non-Randomized Controlled Trial
Annals of emergency medicine

ED Nudge Strategy Increases Naltrexone Prescribing for Alcohol Misuse

A multicomponent emergency department protocol significantly raised naltrexone initiation for patients with alcohol-related diagnoses.

May 17, 2026
Intracranial Stimulation Prevents Attentional Lapses in Children Randomized Controlled Trial
Nature Neuroscience

Intracranial Stimulation Prevents Attentional Lapses in Children

A new study identifies a real-time neural signature for attentional control, enabling targeted intervention to improve attention shifts.

May 15, 2026
Accelerated Deep TMS Protocols Show High Remission Rates in Depression Randomized Controlled Trial
Molecular Psychiatry

Accelerated Deep TMS Protocols Show High Remission Rates in Depression

A randomized trial finds that 10-day accelerated deep TMS protocols achieve 42% to 50% remission rates, exceeding pharmacotherapy alone.

May 13, 2026
Testosterone Therapy Improves Sexual Function After Radical Prostatectomy Randomized Controlled Trial
JAMA Internal Medicine

Testosterone Therapy Improves Sexual Function After Radical Prostatectomy

A phase 2 trial shows 12 weeks of testosterone cypionate enhances libido and body composition without triggering biochemical recurrence.

May 13, 2026
Magnetic Seizure Therapy Limits Memory Loss in Bipolar Depression Trial Randomized Controlled Trial
American Journal of Psychiatry

Magnetic Seizure Therapy Limits Memory Loss in Bipolar Depression Trial

A randomized pilot study shows magnetic seizure therapy matches the efficacy of ultrabrief ECT while reducing cognitive adverse effects.

May 10, 2026
Digital Therapeutic App Reduces Chronic Tinnitus Distress in Randomized Trial Randomized Controlled Trial
JAMA Otolaryngology–Head & Neck Surgery

Digital Therapeutic App Reduces Chronic Tinnitus Distress in Randomized Trial

A mobile application delivering cognitive behavioral therapy significantly improved Tinnitus Handicap Inventory scores over 24 weeks.

May 10, 2026
Autologous Mesenchymal Cells Reduce Neuroinflammation in Chronic Brain Injury Non-Randomized Controlled Trial
Brain

Autologous Mesenchymal Cells Reduce Neuroinflammation in Chronic Brain Injury

A Phase 1/2a trial shows intravenous stromal cells improve white matter integrity and reduce immune cell density in the chronic TBI brain.

May 09, 2026
Mindfulness Adjunct Lowers Anxiety Scores in Medicated Adults With GAD Randomized Controlled Trial
Frontiers in Psychiatry

Mindfulness Adjunct Lowers Anxiety Scores in Medicated Adults With GAD

An 8-week mindfulness program added to pharmacotherapy improved clinician-rated anxiety, sleep quality, and psychosocial functioning.

May 08, 2026
Prefrontal Stimulation Amplifies Placebo Mood Response in Depression Randomized Controlled Trial
JAMA Psychiatry

Prefrontal Stimulation Amplifies Placebo Mood Response in Depression

Intermittent theta burst stimulation of the dorsomedial prefrontal cortex modulates the default mode network to enhance expectancy effects.

May 07, 2026
Psychotherapy Shows Large, Durable Effects in Treatment-Resistant Depression Randomized Controlled Trial
Frontiers in Psychiatry

Psychotherapy Shows Large, Durable Effects in Treatment-Resistant Depression

A reanalysis of trial data suggests clinical gains stem from simultaneous psychological shifts rather than sequential changes in defense.

May 07, 2026
Telehealth Hypnotic Cognitive Therapy Reduces Chronic Pain After Spinal Cord Injury Randomized Controlled Trial
Neurology

Telehealth Hypnotic Cognitive Therapy Reduces Chronic Pain After Spinal Cord Injury

A randomized trial demonstrates that remote delivery of hypnotic cognitive therapy significantly lowers pain intensity and depression.

May 03, 2026
Group CBT Reduces Hostile Attribution Bias in Young Adults With ASD Traits Randomized Controlled Trial
Frontiers in Psychiatry

Group CBT Reduces Hostile Attribution Bias in Young Adults With ASD Traits

A pilot study finds that targeting social cognitive distortions improves communication and quality of life through distinct pathways.

May 02, 2026
Digital Exercise and Interoceptive Training Lower Acute Depression Scores in Young Adults Randomized Controlled Trial
Journal of Affective Disorders

Digital Exercise and Interoceptive Training Lower Acute Depression Scores in Young Adults

A randomized trial found significant short-term symptom reduction, though benefits did not persist at one- or three-month follow-up.

May 02, 2026
Group Cognitive Therapy Reduces Negative Symptoms in Early Psychosis Randomized Controlled Trial
Psychotherapy and psychosomatics

Group Cognitive Therapy Reduces Negative Symptoms in Early Psychosis

A pilot trial shows rumination-focused therapy added to standard care significantly improves negative symptoms and repetitive thinking.

May 01, 2026
Intranasal Ketamine Reduces Existential Distress in Advanced Cancer Patients Randomized Controlled Trial
Journal of Pain and Symptom Management

Intranasal Ketamine Reduces Existential Distress in Advanced Cancer Patients

Secondary analysis shows three doses of intranasal ketamine improve death-related anxiety and existential well-being in palliative care.

May 01, 2026
Behavioral Activation Reduces Pain During Smoking Cessation in Depressed Adults Randomized Controlled Trial
Journal of Affective Disorders

Behavioral Activation Reduces Pain During Smoking Cessation in Depressed Adults

A secondary analysis finds that behavioral activation therapy significantly lowers bodily pain scores compared to standard cessation care.

May 01, 2026
Digital and Primary Care Intervention Reduces Adolescent Depressive Symptoms in Slums Randomized Controlled Trial
JAMA psychiatry

Digital and Primary Care Intervention Reduces Adolescent Depressive Symptoms in Slums

A randomized trial in India shows a multimedia campaign and digital tools improve mental health literacy and lower PHQ-9 scores.

April 30, 2026
2C-B Shows Empathogenic and Psychedelic Effects with Low Cardiovascular Strain Randomized Controlled Trial
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology

2C-B Shows Empathogenic and Psychedelic Effects with Low Cardiovascular Strain

A crossover trial compares 30 mg of 2C-B to MDMA and psilocybin, finding similar emotional empathy and a shorter five-hour duration.

April 30, 2026
Interdisciplinary Whole Health Teams Improve Chronic Pain Function Over Standard Care Randomized Controlled Trial
JAMA

Interdisciplinary Whole Health Teams Improve Chronic Pain Function Over Standard Care

A randomized trial of 764 veterans shows that value-aligned team care reduces pain interference more than group therapy or usual care.

April 30, 2026
Semaglutide Improves Reward-Based Motivation in Patients With Major Depressive Disorder Randomized Controlled Trial
JAMA psychiatry

Semaglutide Improves Reward-Based Motivation in Patients With Major Depressive Disorder

A randomized trial shows oral semaglutide reduces the perceived cost of physical effort in patients with depression and elevated BMI.

April 30, 2026
Online Therapist-Assisted Program Reduces Posttraumatic Stress in Injured Children Randomized Controlled Trial
JAMA Pediatrics

Online Therapist-Assisted Program Reduces Posttraumatic Stress in Injured Children

A randomized trial shows a digital cognitive behavioral intervention lowers symptom scores for six months following pediatric hospitalization.

April 28, 2026
Symptom-Based Dosing Reduces Discharge Time in Neonatal Opioid Withdrawal Randomized Controlled Trial
JAMA

Symptom-Based Dosing Reduces Discharge Time in Neonatal Opioid Withdrawal

A cluster randomized trial shows symptom-based dosing shortens medical readiness for discharge when paired with the Eat, Sleep, Console model.

April 28, 2026
Luvadaxistat Fails to Improve Schizophrenia Cognition in Phase 2 Trial Randomized Controlled Trial
Neuropsychopharmacology

Luvadaxistat Fails to Improve Schizophrenia Cognition in Phase 2 Trial

The ERUDITE study found no significant cognitive benefit from adding the D-amino acid oxidase inhibitor to stable antipsychotic therapy.

April 27, 2026
Physical Therapy Improves Function More Than CBT in Chronic Low Back Pain Randomized Controlled Trial
Annals of Internal Medicine

Physical Therapy Improves Function More Than CBT in Chronic Low Back Pain

A sequential randomized trial finds physical therapy superior for initial functional gains, though secondary strategies show no difference.

April 27, 2026
Counterconditioning Stabilizes Neural Safety Signals in PTSD Randomized Controlled Trial
Translational Psychiatry

Counterconditioning Stabilizes Neural Safety Signals in PTSD

Functional MRI shows pairing threat stimuli with positive outcomes reinforces safety patterns in the ventromedial prefrontal cortex.

April 27, 2026
Pitch Gestures Increase Prefrontal Activation During Mandarin Tone Sandhi Perception Non-Randomized Controlled Trial
Frontiers in Neuroscience

Pitch Gestures Increase Prefrontal Activation During Mandarin Tone Sandhi Perception

Training with physical gestures strengthens functional connectivity in the left dorsolateral prefrontal cortex to improve auditory discrimination.

April 26, 2026